Fibrate Drugs Market: Advancing Cardiovascular Health and Lipid Management
Introduction The Fibrate Drugs Market is projected to grow steadily over the next decade as the global prevalence of cardiovascular diseases and lipid disorders continues to rise. Valued at USD 1.5 billion in 2024, the market is expected to reach USD 1.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 2.12%. Fibrate drugs are primarily prescribed to manage...
0 Comments 0 Shares 643 Views 0 Reviews
iS Wao https://iswao.com